Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease49
Fatty liver and cerebrovascular disease: plausible association and possible mechanisms49
Cholesterol in older age – it matters to mind48
Editorial introductions45
Editorial introduction34
Updates on genetics and molecular biology33
Brain lipid metabolism: the emerging role of lipid droplets in glial cells32
Editorial introductions29
Editorial introduction28
Editorial introduction28
Role of VLDL receptor in atherogenesis26
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review25
Ketogenic therapies in mild cognitive impairment and dementia24
What should be the goal of cholesterol-lowering treatment? A quantitative evaluation dispelling guideline myths24
Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies24
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism23
Early atherogenesis: new insights from new approaches23
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis22
Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm21
ANGPTL4: a new mode in the regulation of intravascular lipolysis20
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events17
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?16
Newborn screening for lipid disorders15
Cardiomyocytes, sphingolipids and cardio myotoxicity15
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease14
Sphingomyelins and ceramides: possible biomarkers for dementia?14
How should low-density lipoprotein cholesterol be calculated in 2022?13
Dietary factors and brain health13
Genetic variation in apolipoprotein A-V in hypertriglyceridemia13
Very long-chain saturated fatty acids and diabetes and cardiovascular disease12
Familial combined hyperlipidemia is a polygenic trait12
Distinct roles of size-defined HDL subpopulations in cardiovascular disease12
Characteristics of plaque lipid-associated macrophages and their possible roles in the pathogenesis of atherosclerosis11
Editorial introductions11
Proprotein convertase subtilisin/kexin type 9 inhibition after acute coronary syndrome or prior myocardial infarction11
Links between ceramides and cardiac function11
Editorial introduction11
Omega-3 fatty acids and cognitive function11
Editorial introductions11
Preprint servers in lipidology: current status and future role10
The power of lipid registries for cardiovascular disease prevention10
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk10
The clinical utility of polygenic risk scores for combined hyperlipidemia9
Altered cardiovascular risk pattern of LDL cholesterol in older adults9
LDL receptor-related protein 1 and its interacting partners in tissue homeostasis9
Exosomes and lipid metabolism in metabolic and cardiovascular disorders9
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
Clinical associations between exercise and lipoproteins9
Diagnosis of remnant hyperlipidaemia8
Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations7
Pregnancy, cardiovascular health, and microchimerism7
Implementation science and genetic testing for familial hypercholesterolemia7
Preeclampsia and fetal growth restriction: does novel proteomics reveal immunological possible candidate biomarkers?7
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?7
Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?7
The iterative lipid impact on inflammation in atherosclerosis7
Strategies for management of patients with elevated lipoprotein(a)7
Angiopoietin-like proteins and postprandial partitioning of fatty acids7
Lipidome and inflammation interplay: the role of diet in this relationship7
0.33890295028687